Immgolis (golimumab-sldi)
Biosimilar
- Region
- 🇺🇸 US
- Active substance
- golimumab-sldi
- Company
- Accord Biopharma Inc.
- Status
- Approved
- FDA approval
- Fri 15 May 2026
- Designations
- Biosimilar
- Application
- BLA761452
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Fri 15 May 2026🇺🇸 FDA approval
FDA approves biosimilar Immgolis (golimumab-sldi)
Accord Biopharma Inc.; BLA761452; Biosimilar; injection · source
Follow Immgolis
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.